论文部分内容阅读
目的:观察穴位刺血配合推拿与药物治疗小儿痰热蕴肺型咳嗽患者的临床疗效及安全性。方法:选取2015年3月~2016年5月我院收治的符合诊断标准的痰热蕴肺型咳嗽患者86例。根据患者入院治疗时间顺序,采用数字随机法,将86例患者分为对照组及观察组,每组患者43例。对照组患者采用小儿肺热咳喘口服液进行治疗,观察组患者采用穴位刺血配合推拿进行治疗。比较两组患者治疗前后临床疗效、症状、临床体征评分及不良反应发生情况。结果:观察组临床疗效总有效率高于对照组(97.69%vs 76.74%),两组患者临床疗效比较差异具有统计学意义(P<0.05);两组患者治疗后临床症状及体征评分较治疗前有明显变化,均呈现下降趋势,两组数据差异具有统计学意义(P<0.05);观察组治疗后咳嗽、咳痰、肺部听诊、烦躁、食欲减退、夜间哭闹评分下降幅度明显高于对照组,两组数据差异具有统计学意义(P<0.05);两组患者在治疗期间均未出现严重不良反应。结论:穴位刺血配合推拿与药物治疗小儿痰热蕴肺型咳嗽患者的临床疗效佳,可有效改善患者临床症状及体征,安全性高,值得临床推广运用。
Objective: To observe the clinical efficacy and safety of acupoint pricking blood with massage and drug treatment for children with phlegm-damp lung type cough. Methods: From March 2015 to May 2016, 86 cases of sputum-heat-phlegm-type cough who meet the diagnostic criteria were selected in our hospital. According to the order of patients’ admission and treatment, 86 patients were divided into control group and observation group by digital random method, with 43 patients in each group. Control group of patients with Hyperactivity Kechuan oral solution for treatment, the observation group of patients with acupoints with massage therapy. The clinical efficacy, symptoms, clinical signs and adverse reactions of the two groups before and after treatment were compared. Results: The total effective rate in the observation group was significantly higher than that in the control group (97.69% vs 76.74%). There was significant difference between the two groups in clinical curative effect (P <0.05) (P <0.05). The cough, sputum, auscultation of the lungs, irritability, loss of appetite and night crying scores decreased significantly in the observation group after treatment In the control group, the difference between the two groups was statistically significant (P <0.05). No serious adverse reactions occurred in both groups during the treatment. Conclusion: Acupoint pricking blood with massage and drug treatment of children with phlegm-damp lung type cough patients with good clinical efficacy, which can effectively improve the clinical symptoms and signs of patients with high safety, it is worthy of clinical promotion and use.